Meningitis is an infection of the meninges, the membranes surrounding the brain and spinal cord. It can be caused by a number of different viral and bacterial pathogens including Haemophilus influenzae b (Hib) and Streptococcus pneumoniae. However, in the US, Neisseria meningitidis is the most common cause of bacterial meningitis in infants and young ... Read more
Market Overview:
The global Meningococcal Vaccines Market is estimated to be valued at US$ 2,965.9 Mn in 2019 and is projected to reach US$ 7,584.3 Mn by 2022. This market research report, published by Coherent Market Insights, highlights that the market is expected to exhibit a CAGR of 12.7% over the forecast period of 2020-2027. Meningococcal vaccines are used to provide immunity against meningococcal disease, a severe infection caused by the ... Read more
The global meningococcal vaccines market is estimated to be valued at US$ 2,965.9 million in 2019 and is expected to exhibit a CAGR of 12.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Meningococcal vaccines are designed to prevent infections caused by Neisseria meningitidis, a bacterium that can cause severe meningitis and septicemia. These vaccines ... Read more
The global Meningococcal Vaccines Market is estimated to be valued at US$ 2,965.9 million in 2019 and is expected to exhibit a CAGR of 12.7% over the forecast period 2020-2027, as highlighted in a new report published by Coherent Market Insights.
Market Overview:
Meningococcal vaccines are used to prevent meningococcal infections, which are caused by the bacteria Neisseria meningitidis. These infections can lead to serious conditions such ... Read more
